SMHC(SH:600131)2025-04-24 12:15Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,111,714,806, representing a 9.14% increase compared to CNY 1,018,612,088 in the same period last year[4] - Net profit attributable to shareholders increased by 117.20% to CNY 26,286,875.67 from CNY 12,102,466.53 year-on-year[4] - Basic and diluted earnings per share both doubled to CNY 0.02 from CNY 0.01, reflecting the growth in net profit[4][8] - The company reported a significant increase in net profit due to revenue growth and improved gross margin[8] - Total operating revenue for Q1 2025 reached ¥1,111,714,806, an increase of 9.14% compared to ¥1,018,612,088 in Q1 2024[20] - Net profit for Q1 2025 was ¥26,280,394, representing a significant increase of 117.5% compared to ¥12,102,466 in Q1 2024[21] - Basic earnings per share for Q1 2025 were ¥0.02, compared to ¥0.01 in Q1 2024, indicating a 100% increase[21] Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -331,512,230.17, worsening from CNY -97,921,382.99 in the same period last year[4] - The total assets at the end of the reporting period were CNY 12,271,064,323.87, a decrease of 4.82% from CNY 12,892,559,602.14 at the end of the previous year[5] - Current assets decreased to CNY 9,487,067,896.92 from CNY 10,133,248,082.89, indicating a decline of approximately 6.4%[15] - Cash and cash equivalents were reported at CNY 2,596,895,498.86, down from CNY 2,893,411,897.68, reflecting a decrease of about 10.3%[15] - The net cash flow from operating activities for Q1 2025 was -¥331,512,230, worsening from -¥97,921,382 in Q1 2024[24] - The company’s total cash inflow from operating activities was ¥2,098,135,933, compared to ¥1,860,154,133 in Q1 2024, representing a growth of 12.78%[24] - The net increase in cash and cash equivalents was -¥178,391,175.37, resulting in an ending balance of ¥2,272,667,156.97[25] Liabilities and Equity - Total liabilities decreased to CNY 5,249,303,816.52 from CNY 5,914,308,226.36, a reduction of approximately 11.2%[16] - The total liabilities decreased to ¥5,456,838,366 in the latest report from ¥6,104,794,158 in the previous period, indicating a reduction of approximately 10.6%[18] - The total equity attributable to shareholders increased to ¥6,814,173,427 from ¥6,787,706,431, reflecting a growth of 0.39%[18] Investments and Expenses - Research and development expenses in Q1 2025 amounted to ¥70,196,137, an increase of 22.5% from ¥57,292,820 in Q1 2024[20] - The company reported an investment income of ¥31,765,453 in Q1 2025, up from ¥27,016,209 in Q1 2024, marking a growth of 17.5%[20] - The company has committed to ongoing investments in new technologies and market expansion strategies to sustain growth[8] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 39,747[10] Other Information - The company has not reported any new product developments or market expansions during the conference call[12] - There were no significant mergers or acquisitions mentioned in the earnings call[12] - The company does not plan to adopt new accounting standards starting from 2025[26]